Concepedia

Publication | Closed Access

Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.

18

Citations

0

References

2015

Year

Gen Hirano, Akitaka Makiyama, Chinatsu Makiyama, Taito Esaki, Hisanobu Oda, Keita Uchino, Masato Komoda, Risa Tanaka, Yuzo Matsushita, Kenji Mitsugi,
PubMed

Abstract

Despite a decrease in the intensity of regorafenib treatment, because of severe adverse events, a fairly favorable efficacy was achieved in Japanese patients.